Scrip World Pharmaceutical News

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Scrip World Pharmaceutical News
Scrip World Pharmaceutical Logo.png
Type News and analysis service
Format Daily online
Owner(s) Informa plc (LSE: INF)
Publisher Philip Jarvis
Editor Mike Ward
Founded March 1972
Headquarters Telephone House
69-77 Paul St
London
EC2A 4LQ
England
Website www.scripnews.com

Scrip Intelligence (Scrip) is an English language international pharmaceutical news, analysis and data service. First published as a weekly print newsletter in March 1972, Scrip included articles on side-effects, regulatory changes and mergers and acquisitions. Scrip World Pharmaceutical News was initially published by advertising company J Walter Thomson but was bought by its e Dr Philip J Brown in 1976 for £2000, who founded PJB Publishing. Brown sold Scrip, associated titles and his company to Informa for £150 million in 2003.[1][2][3] Scrip has now developed into an online global pharma news and analysis service. It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials.

Scrip subscriber base[edit]

The Scrip readership has grown to over 100,000 worldwide,[4] half of which are in Europe. Scrip is read by managers and executives working across all disciplines in pharmaceutical and biotech companies worldwide.[5]

Editors[edit]

  • Barbara Obstoj (1972–76)
  • Philip Brown (1977–86)
  • Moira Dower (1986–96)
  • John Davis (1997-2007)
  • Alex Shimmings (2007-2010)
  • Mike Ward (2010–present)

Scrip editorial team[edit]

Scrip has a large independent editorial team of 21. The journalists are based throughout the world in Washington, D.C., Tokyo, India, and London to ensure a global emphasis to the latest news stories.

  • "Science desk" - The R&D section tracks the fortune of marketed and developmental drugs, from clinical data to their passage through the regulatory process.[6][7]
  • "Europe coverage" - Scrip's Europe based desk covers all the political and regulatory developments that affect the pharmaceutical industry in the 27 member states, other European countries and the Russian Federation.
  • "US coverage" - Scrip's US team details the political developments from Washington affecting the global pharma industry, such as U.S. Food and Drug Administration safety and regulatory matters, as well as litigation, Generics and pharmacy.[8]
  • "World coverage" - Scrip's locally based world coverage focuses on Japan and other Pacific Rim markets, Asia and Latin America.
  • "Business news" - Scrip's global reporters bring information on financial and business affairs in the pharma and biotech sectors.[9]
  • "Analyst team" - Scrip's analysts offer an insight into the industry's more significant developments.[10]

References[edit]

  1. ^ Wray, Richard (2003-12-03). "£2,000 niche buy nets £150m for science journalist". The Guardian. ISSN 0261-3077. Retrieved 2016-10-12. 
  2. ^ "Three new Square fellows". Pharmaceutical Journal. Retrieved 2016-10-12. 
  3. ^ "Informa buys PJB Publications for £120m – Press Gazette". www.pressgazette.co.uk. Retrieved 2016-10-12. 
  4. ^ "Scrip's readership reaches over 100,000". scripnews.com. Retrieved 2008-08-04. 
  5. ^ "Scrip's readers are global mid-senior level management". scripnews.com. Retrieved 2008-08-04. 
  6. ^ "Research and development news". scripnews.com. Retrieved 2008-08-04. 
  7. ^ "Clinical trials news". scripnews.com. Retrieved 2008-08-04. 
  8. ^ "Policy and regulation news". scripnews.com. Retrieved 2008-08-04. 
  9. ^ "Financial news". scripnews.com. Retrieved 2008-08-04. 
  10. ^ "Scrip's analysis team". scripnews.com. Retrieved 2008-08-04. 

External links[edit]